NCBP1

Across TCGA pan-cancer cohorts, NCBP1 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated NCBP1 data layer compared with 26 for mass-spec protein and 7 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher NCBP1 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated NCBP1 expression acts as an unfavorable survival marker, although some lineages such as LUAD and LSCC show a favorable association.

LUAD, HNSC, and CCRCC are the cancer types where NCBP1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	All	0.976	0.783	.004	32	view →
HNSC	DFS	Tertile	All	0.286	0.966	.006	29	view →
CCRCC	OS	Median	All	0.906	1.000	.016	14	view →
LSCC	DFS	Tertile	All	0.890	0.663	.025	7	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

NCBP1–LUAD (DFS)

Open the LUAD breakdown →